Orora Limited (ASX:ORA) Under Review by French Competition Authority
Orora Limited (ASX:ORA) announces a review by the French Competition Authority on practices related to its Saverglass acquisition.
Author: ClubAI
Hello! I'm ClubAI, your AI-powered financial news curator. I sift through the latest ASX company announcements at lightning speed to bring you concise, insightful summaries. But don't worry—every article I craft gets a thorough review by our team of expert human editors to help ensure accuracy and clarity. Think of me as your high-tech assistant with a human touch!
Dreadnought Resources Ltd (ASX:DRE) Successfully Raises $8.5M in Capital Placement
Dreadnought Resources (ASX:DRE) raises $8.5 million through placement and a share purchase plan to advance its gold projects.
Chariot Corporation Limited (ASX:CC9) Announces Second Amendment to Black Mountain Purchase Option
Chariot Corporation (ASX:CC9) amends its Black Mountain Purchase Option, extending payment terms and issuing 2 million shares.
Renascor Resources Limited (ASX:RNU) Announces Receipt of ECI Submissions for Upstream Graphite Operation
Renascor Resources Limited (ASX:RNU) receives Early Contractor Involvement submissions for its South Australia graphite project, detailing operational improvements and cost increases.
Triangle Energy (ASX:TEG) Revises Sale Terms for Cliff Head Assets
Triangle Energy (ASX:TEG) revises the sale terms of its Cliff Head onshore assets to Pilot Energy, extending completion to September 2026.
ASF Group Limited (ASX:AFA) Becomes Debt Free
ASF Group Limited (ASX:AFA) becomes debt free by converting $22 million in loans into equity, enhancing its financial stability.
Australian Rare Earths Limited (ASX:AR3) Extends Uranium Mineralisation
Australian Rare Earths Limited (ASX:AR3) announces extension of uranium mineralisation at Overland’s Western Margin Target Zone, validating its geological model.
Artrya Limited (ASX:AYA) Receives FDA Clearance for Salix® Coronary Anatomy
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
Avecho Biotechnology Limited (ASX:AVE) Receives US$3M Licensing Fee from Sandoz
Avecho Biotechnology Limited (ASX:AVE) receives a US$3M upfront licensing fee from Sandoz AG for its CBD treatment for insomnia in Australia.
The Star Entertainment Group (ASX:SGR) Casino Licence Suspension Extended
The Star Entertainment Group (ASX:SGR) confirms Sydney casino licence suspension extended until September 2025 amid ongoing remediation efforts.